Investigators successfully tested an acellular tissue engineered vessel for hemodialysis vascular access in patients at high-risk for arteriovenous fistula (AVF) maturation failure.

Steroidal mineralocorticoid receptor antagonists (MRAs) may not lower risk for all-cause or cardiovascular (CV) mortality among patients receiving maintenance dialysis, according to a meta-analysis ...

Researchers at Yale School of Medicine have determined that a panel of biomarkers can help physicians better understand ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has asked Fresenius Medical ...

Researchers have found in phase 3 ORIGIN 3 trial that investigational dual BAFF/APRIL inhibitor atacicept significantly ...

A new study of more than 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

About 48% of fully vaccinated COVID patients suffered kidney damage during their infection, compared with 42% unvaccinated ...

Herbal supplements, despite their perceived natural safety, pose significant risks to liver and kidney health due to ...

Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated ...

A new study of over 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long-term ...

EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive’ ...